WU Yibing

Head of China, Joint Head of Enterprise Development group for Temasek

Wu Yibing joined Temasek in October 2013. He currently serves as Head of China, overseeing Temasek’s investment activities in China, which currently forms 27% of Temasek’s net portfolio value. He is also the Joint Head of Enterprise Development Group.

Prior to joining Temasek, Yibing was previously President of CITIC Private Equity Funds Management, a position he held since December 2009. He concurrently served as Chairman and Chief Executive Officer of Goldstone Investment Co. Ltd.,

Yibing began his career with McKinsey, rising to become Senior Partner and Head of Asia Pacific M&A Practice. He was also General Manager of McKinsey Beijing, where he was responsible for providing M&A, corporate restructuring and IPO advisory for large Chinese enterprises. He had advised a number of leading Asian companies in their international expansion effort. He subsequently joined the Lenovo Group, and led the acquisition and integration of the IBM PC business, serving as Chief Strategy Officer, Chief Integration Officer, Chief Transformation Officer/ Chief Information Officer of Lenovo Group.

Yibing was later appointed to Lenovo parent Legend Holdings, as Executive Vice President responsible for the overall business operations and overseeing its direct investment business.

Since Nov 2019, he has been Board Member of Gavi, the Vaccine Alliances. Yibing also serves on the board of China Social Entrepreneur Foundation.

Yibing holds a Doctor of Philosophy degree (PhD) in Biochemistry from Harvard University and a Bachelor of Science degree (BSc.) in Molecular Biology from University of Science and Technology of China.